Affirm: Morgan Stanley trims target to $79, Monness Crespi starts with Buy
Morgan Stanley cut its Affirm price target to $79 from $82, while Monness Crespi initiated at Buy with a $90 target ahead of the Nov. 5 results.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to Stocktwits, Affirm Holdings shares fell 0.3% in overnight trading late Monday, extending a losing streak to four sessions. Investors weighed interest-rate concerns ahead of this week's Federal Reserve decision.
Morgan Stanley lowered its price target on Affirm to $79 from $82 and kept its Equal Weight rating. The new target still implies more than 13% upside from the last close. The bank expects fiscal first-quarter gross merchandise value growth of about 34%, above the company's outlook of about 31%, though it believes the buy side is nearer 37%.
Monness Crespi initiated coverage with a Buy rating and a $90 target. The analyst said the buy-now-pay-later firm's share of spending, and that of neobanks, has risen meaningfully over the past decade.
why it matters
Analysts expect revenue of $1.21 billion, up nearly 30% from $933.34 million a year earlier, and earnings per share of $0.38 versus $0.23. The stock is down about 6% year to date, and retail sentiment on Stocktwits was bearish, so the report will be closely watched.
tags
instruments
sources
- AFRM Stock Clocks 4 Days In The Red: One Analyst Still Sees 13% Upside After Trimming Target — Stocktwits, 27 October 2026 at 01:33 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗